Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Oct 13;34(4):339–347. doi: 10.1093/ajh/hpaa168

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020. Published by Oxford University Press on behalf of American Journal of Hypertension, Ltd. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)

PMC Copyright notice

Figure 3. — Odds of COVID-19 hospitalization in relation to use of RAAS inhibitors, among individuals with COVID-19 infection. Estimates are adjusted for age, sex, race/ethnicity, diabetes, hypertension, HF, prior MI, asthma or COPD, and Charlson comorbidity score. Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker; CI, confidence interval; COPD, chronic obstructive pulmonary disease; COVID-19, coronavirus disease 2019; DDD, defined daily dose; HF, heart failure; MI, myocardial infarction; OR, adjusted odds ratio; RAAS, renin–angiotensin–aldosterone system.